VI
BNGO icon

Versor Investments’s Bionano Genomics BNGO Stock Holding History

Versor Investments’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-99
Closed -$86.6K – 714
2022
Q4 		$86.6K Sell
99
-101
-51% -$127K 0.01% 684
2022
Q3 		$220K Sell
200
-29
-13% -$38.3K 0.01% 709
2022
Q2 		$190K Buy
229
+162
+242% +$167K 0.01% 746
2022
Q1 		$104K Sell
67
-62
-48% -$83.7K ﹤0.01% 598
2021
Q4 		$231K Buy
+129
New +$345K 0.01% 469

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Versor Investments's BNGO Position: Q1 2023 in Review

Versor Investments sold out of Bionano Genomics (BNGO) in Q1 2023, closing a stake of 99 shares — an estimated $86.6K sold.

Versor Investments first reported a position in BNGO in Q4 2021 and held it in 5 quarters. The position peaked at $231K in Q4 2021. 126 funds tracked by Wall St. Rank hold BNGO as of Q1 2023.

  • Versor Investments reported no remaining Bionano Genomics position as of Q1 2023 after selling out during the quarter.
  • Versor Investments sold 99 Bionano Genomics shares in Q1 2023, an estimated $86.6K.
  • Versor Investments first reported a position in Bionano Genomics in Q4 2021 and held it in 5 quarters.
  • Versor Investments's Bionano Genomics position peaked at $231K in Q4 2021.
  • 126 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2023.

Based on Versor Investments's 13F filing for Q1 2023, filed 5 May 2023.